Immune responses against oncolytic adenovirus (Ad) vectors are thought to limit vector anti-tumor efficacy. With Syrian hamsters, which are immunocompetent and whose tumors and normal tissues are ...
NK4 or adenovirus vector expressing NK4 (Ad-NK4) can act bifunctionally as a hepatocyte growth factor antagonist and angiogenesis inhibitor and has potential value in cancer therapy. The aim of this ...
New York [USA], Jan 1 (ANI): Mastering the targeted delivery of therapeutic genes to the desired location within the body is the first necessary step towards implementing gene therapy to treat renal ...
New Rochelle, NY, August 13, 2018--A new study has shown that a single injection of a novel adeno-associated vector (AAV)-based therapy can result in improved enzyme activ-ity and glycogen clearance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results